Monday, September 27, 2021 11:49:46 AM
This is all easily short term items for Koos. Alliances and licensing agreements are real Keys here. Biopharms are looking for this IP..
During the coming months I shall endeavor to achieve the following milestones:
SHORT TERM GOALS
1)Settle all outstanding convertible notes payable in order that the Company will have no convertible instruments outstanding.
2)Hire a Chief Scientific Officer
3)Seek out and enter into alliances, co-development agreements and additional licensing agreements with regard to our proprietary mRNA and NR2F6 portfolios.
4)Obtain OTCQB listing for our securities on the OTC Market.
5)Establish a social media presence in order to more easily provide updates to our shareholders, the investment community, the scientific community and the public at large.
I think its greed looking for a fast buck moves the $$$ around the OTC this week then poof alot of tickers GONE. This will turn to a dime and they will have missed these cheapies.
Just My 2 Bits The truth is incontrovertible. Malice may attack it,
ignorance may deride it, but in the end, there it is. Do Your Own
DD Do not take my Stock post Opinions as investing advice. Nothing I say is financial advise.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM